Global In Vitro Diagnostic Market Analysis
A new market research report on the In Vitro Diagnostic market is now available in the reportlinker.com catalogue.
News
OneMedForum NY 2011 Trans-Atlantic Conference Promises Quality Connections
OneMedPlace is gearing up for OneMedForum NY 2011, the company’s 2nd annual Trans-Atlantic Conference to be held June 23-24 , 2011 in New York City.
Burrill Builds Digital Health Team
Burrill & Company recently announced that Dr. Dirk Lammerts has been appointed as Managing Director of Digital Health.
Accord Biosciences Receives $1.3M NIH SBIR Grant To Develop Pulmonary Hypertension Diagnostic
Last year, Accord Biosciences was awarded a Phase II National Institutes of Health Small Business Innovation Research grant of $1.3M to develop a point-of-care diagnostic for pulmonary arterial hypertension.
Compumedics System: World’s first accredited and paperless sleep lab
Compumedics Grael High-Definition PSG/EEG system and their ProFusion nexus Lab Management system, is now the world’s first accredited and paperless sleep lab’s database monitoring technology of choice.
Colon Cancer Screening made Simple
Women should be aware that they have several options for colon cancer screening, and not only the often-dreaded colonoscopy, according to a new report from the American College of Obstetricians and Gynecologists.
Second Sight Develops A Second Chance for the Blind
An implant designed to restore a degree of sight to people with advanced retinal degenerative diseases has been approved for sale in the European Economic Area.
Akonni Biosystems Inks Agreement with Lead Medical Research Laboratory
Akonni Biosystems, a molecular diagnostics company that develops rapid, low-cost and highly scalable solutions for infectious disease testing has signed a license agreement with the U.S. Army Medical Research Institute of Infectious Diseases.
EpiCept Corporation Announces Year End Results and Updates On Clinical Trials Surrounding Cancer Treatment
EpiCept Corporation recently announced operating and financial results for the year 2010, and provided an update on its key business initiatives.
Breakthrough Study Indicates CNS Response’s Referenced-EEG Enables Physicians to Significantly Improve Success Rates in Treating Depression
According to The Journal of Psychiatric Research, a breakthrough study by CNS Response, Inc. (OTCBB: CNSO), reveals that physicians using CNS’s Referenced-EEG® (rEEG), an online reference database, were able to significantly improve their success in treating patients with depression, including patients with treatment-resistant depression.